Plain-English translation of NCT07409181 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with systemic lupus erythematosus (SLE), a serious autoimmune disease. Researchers want to find out which dose of this medication works best and is safest. You would continue taking your regular lupus medications while also taking the new treatment.
People with lupus need better treatment options to control their symptoms and prevent organ damage. This medication is being studied to see if it could offer improvement when added to standard care.
You likely qualify if…
You likely don't qualify if…
You would take a daily pill for one year — either the new medication at one of four different doses or a placebo (a pill with no medicine). You would be assigned randomly to one of these five groups. During the study, you'll visit the clinic regularly so doctors can check your health, monitor for side effects, and measure whether the medication is helping. The entire study lasts a bit longer than one year from start to finish.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
United States